Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $11.3 Million - $13.9 Million
328,982 Added 20.95%
1,899,497 $80 Million
Q1 2023

May 15, 2023

SELL
$33.32 - $40.98 $4.68 Million - $5.76 Million
-140,588 Reduced 8.22%
1,570,515 $55.9 Million
Q4 2022

Feb 14, 2023

BUY
$25.32 - $51.45 $25.7 Million - $52.3 Million
1,016,660 Added 146.4%
1,711,103 $62.8 Million
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $5.52 Million - $9.39 Million
118,680 Added 20.61%
694,443 $32.7 Million
Q2 2022

Oct 27, 2022

BUY
$63.06 - $84.75 $21.2 Million - $28.5 Million
336,610 Added 140.75%
575,763 $41.3 Million
Q2 2022

Aug 15, 2022

BUY
$63.06 - $84.75 $21.2 Million - $28.5 Million
336,610 Added 140.75%
575,763 $41.3 Million
Q1 2022

Oct 27, 2022

SELL
$74.15 - $99.36 $25 Million - $33.4 Million
-336,610 Reduced 58.46%
239,153 $19.4 Million
Q1 2022

May 13, 2022

SELL
$74.15 - $99.36 $55.1 Million - $73.9 Million
-743,705 Reduced 75.67%
239,153 $19.4 Million
Q4 2021

Feb 14, 2022

SELL
$86.01 - $102.89 $23.7 Million - $28.3 Million
-275,213 Reduced 21.88%
982,858 $101 Million
Q3 2021

Nov 15, 2021

BUY
$84.7 - $96.31 $107 Million - $121 Million
1,258,071 New
1,258,071 $110 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.